Point72 Asia (Singapore)’s HilleVax HLVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,986
Closed -$45.7K 1060
2025
Q2
$45.7K Buy
+22,986
New +$42K 0.01% 607

Point72 Asia (Singapore)'s HLVX Position: Q3 2025 in Review

Point72 Asia (Singapore) sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 22,986 shares — an estimated $45.7K sold.

Point72 Asia (Singapore) first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $45.7K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

  • Point72 Asia (Singapore) reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 22,986 HilleVax shares in Q3 2025, an estimated $45.7K.
  • Point72 Asia (Singapore) first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
  • Point72 Asia (Singapore)'s HilleVax position peaked at $45.7K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.